Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Proceedings of the American Thoracic Society 5:207-217 (2008)
© 2008 The American Thoracic Society
doi: 10.1513/pats.200708-139MG

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tasali, E.
Right arrow Articles by Ip, M. S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tasali, E.
Right arrow Articles by Ip, M. S. M.

Obstructive Sleep Apnea and Metabolic Syndrome

Alterations in Glucose Metabolism and Inflammation

Esra Tasali1 and Mary S. M. Ip2

1 Department of Medicine, University of Chicago, Chicago, Illinois; and 2 Department of Medicine, Queen Mary Hospital, University of Hong Kong, Pokfulam, Hong Kong Special Administrative Region, People's Republic of China

Correspondence and requests for reprints should be addressed to Esra Tasali, M.D., Section of Pulmonary and Critical Care Medicine, Department of Medicine, University of Chicago, 5841 S. Maryland Avenue, MC 6026, Chicago, IL 60637. E-mail: etasali{at}medicine.bsd.uchicago.edu

ABSTRACT

Metabolic syndrome (MS), the commonly used term for the clustering of obesity, insulin resistance, hypertension, and dyslipidemia, affects millions of people worldwide, and is associated with an increased risk of cardiovascular disease and type 2 diabetes. Recently, it has been suggested that obstructive sleep apnea (OSA), an increasingly prevalent condition, may contribute to the development of MS and diabetes. Despite substantial evidence from both clinical and population studies to suggest an independent link between OSA and metabolic abnormalities, the issue still remains controversial. Obesity, particularly visceral obesity, is an important factor in the assessment of adverse metabolic outcome in OSA. Further prospective and interventional studies, with adequate sample sizes and longer follow-up, rigorous control for adiposity, and, ideally, randomization and control for any therapeutic intervention, are clearly needed to address the direction of causality. There are multiple mechanistic pathways involved in the interaction between OSA, obesity, and metabolic derangements. Chronic intermittent hypoxia and sleep fragmentation with sleep loss in OSA are likely key triggers that initiate or contribute to the sustenance of inflammation as a prominent phenomenon, but their complex interplay remains to be elucidated. In summary, OSA may represent a novel risk factor for MS and diabetes, and thus clinicians should be encouraged to systematically evaluate the presence of metabolic abnormalities in OSA and vice versa.

Key Words: sleep apnea • metabolic syndrome • glucose metabolism • inflammation




This article has been cited by other articles:


Home page
Eur Respir JHome page
P. Levy, M. R. Bonsignore, and J. Eckel
Sleep, sleep-disordered breathing and metabolic consequences
Eur. Respir. J., July 1, 2009; 34(1): 243 - 260.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
D. C-L. Lam, A. Xu, K. S-L. Lam, B. Lam, J. C-M. Lam, M. M-S. Lui, and M. S-M. Ip
Serum adipocyte-fatty acid binding protein level is elevated in severe OSA and correlates with insulin resistance
Eur. Respir. J., February 1, 2009; 33(2): 346 - 351.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
J. M. Parish
Sleep-Related Problems in Common Medical Conditions
Chest, February 1, 2009; 135(2): 563 - 572.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. M. Punjabi and B. A. Beamer
Alterations in Glucose Disposal in Sleep-disordered Breathing
Am. J. Respir. Crit. Care Med., February 1, 2009; 179(3): 235 - 240.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
M. S M Ip
Obstructive sleep apnoea, insulin resistance and sleepiness
Thorax, November 1, 2008; 63(11): 939 - 940.
[Full Text] [PDF]


Home page
ThoraxHome page
A Barcelo, F Barbe, M de la Pena, P Martinez, J B Soriano, J Pierola, and A G N Agusti
Insulin resistance and daytime sleepiness in patients with sleep apnoea
Thorax, November 1, 2008; 63(11): 946 - 950.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Tasali, E. Van Cauter, L. Hoffman, and D. A. Ehrmann
Impact of Obstructive Sleep Apnea on Insulin Resistance and Glucose Tolerance in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3878 - 3884.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
D. K. Ng, K.-l. Kwok, and C.-h. Chan
Re: The Association Between Hay Fever and Stroke in a Cohort of Middle Aged and Elderly Adults
J Am Board Fam Med, September 1, 2008; 21(5): 477 - 478.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the American Thoracic Society.